
    
      Tranexamic acid, an inhibitor of fibrinolysis, has proven to be effective in reducing
      perioperative blood loss in patients undergoing total hip and knee arthroplasty. However,
      limited numbers of well-controlled trials in spinal surgery have been conducted due to
      heterogeneity in the performed surgical procedures.
    
  